258 related articles for article (PubMed ID: 18774108)
1. Can inhibition of IKur promote atrial fibrillation?
Burashnikov A; Antzelevitch C
Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
[TBL] [Abstract][Full Text] [Related]
2. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.
Wettwer E; Hála O; Christ T; Heubach JF; Dobrev D; Knaut M; Varró A; Ravens U
Circulation; 2004 Oct; 110(16):2299-306. PubMed ID: 15477405
[TBL] [Abstract][Full Text] [Related]
3. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
4. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
5. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
[TBL] [Abstract][Full Text] [Related]
7. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
[TBL] [Abstract][Full Text] [Related]
8. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
Courtemanche M; Ramirez RJ; Nattel S
Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKur/Ito block.
Burashnikov A; Mannava S; Antzelevitch C
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2393-400. PubMed ID: 15148061
[TBL] [Abstract][Full Text] [Related]
10. The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation.
Ford J; Milnes J; El Haou S; Wettwer E; Loose S; Matschke K; Tyl B; Round P; Ravens U
Heart Rhythm; 2016 Feb; 13(2):555-64. PubMed ID: 26455450
[TBL] [Abstract][Full Text] [Related]
11. The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.
Sridhar A; da Cunha DN; Lacombe VA; Zhou Q; Fox JJ; Hamlin RL; Carnes CA
Br J Pharmacol; 2007 Nov; 152(6):870-9. PubMed ID: 17700726
[TBL] [Abstract][Full Text] [Related]
12. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization.
Yue L; Feng J; Li GR; Nattel S
J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):647-62. PubMed ID: 8930833
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of I
Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
16. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.
de Haan S; Greiser M; Harks E; Blaauw Y; van Hunnik A; Verheule S; Allessie M; Schotten U
Circulation; 2006 Sep; 114(12):1234-42. PubMed ID: 16940189
[TBL] [Abstract][Full Text] [Related]
17. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
18. Rate-Dependent Role of I
Aguilar M; Feng J; Vigmond E; Comtois P; Nattel S
Biophys J; 2017 May; 112(9):1997-2010. PubMed ID: 28494969
[TBL] [Abstract][Full Text] [Related]
19. Potential ionic mechanism for repolarization differences between canine right and left atrium.
Li D; Zhang L; Kneller J; Nattel S
Circ Res; 2001 Jun; 88(11):1168-75. PubMed ID: 11397783
[TBL] [Abstract][Full Text] [Related]
20. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.
Burashnikov A; Petroski A; Hu D; Barajas-Martinez H; Antzelevitch C
Heart Rhythm; 2012 Jan; 9(1):125-31. PubMed ID: 21884675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
